Invention Grant
US08741903B2 Organic compound for use in the treatment of hepatocellular cancer (HCC)
有权
用于治疗肝细胞癌（HCC）的有机化合物
- Patent Title: Organic compound for use in the treatment of hepatocellular cancer (HCC)
- Patent Title (中): 用于治疗肝细胞癌（HCC）的有机化合物
-
Application No.: US13641668Application Date: 2011-04-14
-
Publication No.: US08741903B2Publication Date: 2014-06-03
- Inventor: Diana Graus Porta , Herbert Schmid , Michael Shi
- Applicant: Diana Graus Porta , Herbert Schmid , Michael Shi
- Applicant Address: CH Basel
- Assignee: Novartis AG
- Current Assignee: Novartis AG
- Current Assignee Address: CH Basel
- Agent Gregory Ferraro
- International Application: PCT/EP2011/055906 WO 20110414
- International Announcement: WO2011/128403 WO 20111020
- Main IPC: A61K31/496
- IPC: A61K31/496
Abstract:
The present invention relates to the method of treating hepatocellular cancer (HCC) with 4-amino-5-fluoro-3-[6-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl]-1H-quinolin-2-one or a pharmaceutically acceptable salt or a tautomer thereof, or a hydrate or a solvate.
Public/Granted literature
- US20130123272A1 ORGANIC COMPOUND FOR USE IN THE TREATMENT OF LIVER CANCER Public/Granted day:2013-05-16
Information query
IPC分类:
